Digitalization of pathology using deep learning and artificial intelligence

Inify,&nbsp;ContextVision’s&nbsp;first digital pathology product for diagnosis of prostate cancer using deep learning and artificial intelligence, is on track regarding commercialisation.

A paradigm shift in the diagnosis of prostate cancer

ContextVision just launched the Company’s first CE marked digital pathology product based on artificial intelligence using deep learning technologies. In this podcast the Company’s CEO Fredrik Palm and Dr. Filippo Fraggetta, the chief pathologist at the Cannizzaro Hospital, will talk about the revolution we are approaching within digital pathology.

Digital Pathology

ContextVision trailer

ContextVision is a medical technology software company that specializes in image analysis and artificial intelligence. As the global market leader within image enhancement, ContextVision is a software partner to leading medical imaging manufacturers around the world.

Share

ContextVision’s podcast

A paradigm shift in the diagnosis of prostate cancer

More episodes

View all episodes

Digital Pathology

ContextVision trailer